Trial in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase Ib CROSSWALK-a Trial Evaluating the Safety of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOEs) in Patients with Sickle Cell Disease (SCD)

被引：7

作者：

Bartolucci, Pablo ^{[1
,2
]}

Ataga, Kenneth I. ^{[3
]}

Callaghan, Michael U. ^{[4
]}

De Franceschi, Lucia ^{[5
,6
]}

Minniti, Caterina ^{[7
]}

Alexandrou, Ari ^{[8
]}

Imbs, Diane-Charlotte ^{[9
]}

Fox, Richard ^{[10
,11
]}

Patel, Himika ^{[11
]}

Sostelly, Alexandre ^{[12
]}

Schimmel, Jonathan ^{[13
]}

机构：

[1] Univ Paris East Creteil, Henri Mondor Univ Hosp, APHP, Sickle cell referral Ctr UMGGR, Creteil, France

[2] Univ Paris East Creteil, Lab Excellence LABEX GRex, IMRB, Creteil, France

[3] UTHSC Ctr Sickle Cell Dis, Memphis, TN USA

[4] Cent Michigan Univ, Childrens Hosp Michigan, Div Pediat Hematol Oncol, SOM, Detroit, MI USA

[5] Univ Verona, Dept Med, Verona, Italy

[6] AOUI Verona, Verona, Italy

[7] Albert Einstein Coll Med, Bronx, NY USA

[8] Roche Prod Ltd, Welwyn Garden City, Herts, England

[9] Certara Inc, Paris, France

[10] Genentech Inc, San Francisco, CA USA

[11] Parexel Int, Nottingham, England

[12] F Hoffmann Roche Ltd, Basel, Switzerland

[13] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY USA

来源：

关键词：

D O I：

10.1182/blood-2021-147854

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3108

引用

页数：5